Italian study backs neonatal ECG screening:
This article was originally published in Clinica
In what supports the implementation of neonatal ECG screening programmes, an Italian study of over 21,000 newborns has found that an ECG performed in the first month of life identifies abnormalities associated with risk of cardiovascular disease and death. Neonatal ECG can also prompt early identification of still asymptomatic infants with cardiovascular malformations, thus allowing therapeutic interventions, including surgery, before the development of irreversible or serious cardiac damage, said the researchers, led by Marco Stramba-Badiale, of the IRCCS Instituto Auxologico Italiano, in Milan. The study was presented this month at the American Heart Association meeting, in New Orleans.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.